Why is Awakn Life Sciences Corp. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-56.90%
EBIT Growth (5y)
-220.59%
EBIT to Interest (avg)
-4.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.60
EV to EBIT
-1.43
EV to EBITDA
-1.44
EV to Capital Employed
-1.70
EV to Sales
3.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Awakn Life Sciences Corp.
Operating Cash Flow
Highest at CAD -1.19 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Net Profit
Higher at CAD -0.74 MM
than preceding 12 month period ended Oct 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CAD MM)
Net Profit
At CAD -0.74 MM has Grown at 59.02%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
Operating Profit
Highest at CAD -0.47
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Here's what is not working for Awakn Life Sciences Corp.
Net Sales
At CAD 0.01 MM has Grown at -72.62%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CAD MM)
Raw Material Cost
Grown by 128.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






